Literature DB >> 18095075

Surgeons' knowledge of quality indicators for gastric cancer surgery.

Lucy K Helyer1, Catherine O'Brien, Natalie G Coburn, Carol J Swallow.   

Abstract

BACKGROUND: Gastric cancer survival in the West is inferior to that achieved in Asian centers. While differences in tumor biology may play a role, poor quality surgery likely contributes to understaging. We hypothesize that the majority of surgeons performing gastric cancer surgery in North America are unaware of the recommended standards.
METHODS: Using the Ontario College of Physicians and Surgeons registry, surgeons who potentially included gastric cancer surgery in their scope of practice were identified. A questionnaire was mailed to 559; of those, 206 surgeons reported managing gastric cancer. Results were evaluated by chi(2) and logistic regression; P < 0.05 was considered significant.
RESULTS: Eighty-six percent of respondents were male and 53% practiced in an urban nonacademic setting. Forty percent reported operating on two to five cases of gastric cancer per year, and 42% on fewer than two cases per year. One-third of surgeons identified 4 cm or less to be the desired gross proximal margin. Half used frozen section to evaluate margin status. Twenty percent of surgeons were unsure of the number of lymph nodes (LN) needed to accurately stage gastric cancer, and the median number reported by the remainder was 10 (range, 0-30). Only 16 of 206 identified both a proximal margin of 5 cm or less and 15 or more LN as desired targets. Those performing more than five gastric resections per year were more likely to report a D2 resection (P = 0.008).
CONCLUSION: The majority of surgeons operating on gastric cancer in Ontario did not identify recommended quality indicators of gastric cancer surgery. A continuing medical education program should be designed to address this knowledge gap to improve the quality of surgery and patient outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 18095075     DOI: 10.1007/s10120-007-0435-6

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  42 in total

1.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

2.  Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group.

Authors:  J D Roder; K Böttcher; R Busch; C Wittekind; P Hermanek; J R Siewert
Journal:  Cancer       Date:  1998-02-15       Impact factor: 6.860

3.  Post-operative radiochemotherapy for gastric cancer: adoption and adaptation.

Authors:  J Ringash; S J Khaksart; A Oza; J Couture; B Japp; M Moore; L L Siu; D Hedley; C Swallow; S Wong; B Cummings; J Kim; R Wong; J Brierley
Journal:  Clin Oncol (R Coll Radiol)       Date:  2005-04       Impact factor: 4.126

4.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

5.  Is gastric carcinoma different between Japan and the United States?

Authors:  Y Noguchi; T Yoshikawa; A Tsuburaya; H Motohashi; M S Karpeh; M F Brennan
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

6.  Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection?

Authors:  Robert C G Martin; David P Jaques; Murray F Brennan; Martin Karpeh
Journal:  J Am Coll Surg       Date:  2002-05       Impact factor: 6.113

Review 7.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

8.  Effect of microscopic resection line disease on gastric cancer survival.

Authors:  S H Kim; M S Karpeh; D S Klimstra; D Leung; M F Brennan
Journal:  J Gastrointest Surg       Date:  1999 Jan-Feb       Impact factor: 3.267

9.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

10.  Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti; F Calvo
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

View more
  5 in total

1.  Geographic variation in surgical practice patterns and outcomes for resected nonmetastatic gastric cancer in Ontario.

Authors:  A L Mahar; A El-Sedfy; M Dixon; M Siddiqui; M Elmi; A Ritter; J Vasilevska-Ristovska; Y Jeong; L Helyer; C Law; B Zagorski; N G Coburn
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

2.  Retrospective assessment of patterns of recurrence relative to radiotherapy volumes for adjuvant conformal chemoradiotherapy in gastric cancer.

Authors:  Tatiana Conrad; Steve MacLellan; Zahra Kassam; Helen Mackay; Ida Khalili; Jenna Sykes; Tom Purdie; Allan Okrainec; Jolie Ringash
Journal:  Gastric Cancer       Date:  2015-09-11       Impact factor: 7.370

3.  Modern treatment of cerebral metastases: Integrated Medical Learning(SM) at CNS 2007.

Authors:  Michael A Vogelbaum; Anthony L Asher; Douglas Kondziolka; Nicholas M Boulis; Nathan R Selden; Brian L Hoh; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

4.  Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.

Authors:  Stephen R Smalley; Jacqueline K Benedetti; Daniel G Haller; Scott A Hundahl; Norman C Estes; Jaffer A Ajani; Leonard L Gunderson; Bryan Goldman; James A Martenson; J Milburn Jessup; Grant N Stemmermann; Charles D Blanke; John S Macdonald
Journal:  J Clin Oncol       Date:  2012-05-14       Impact factor: 44.544

5.  Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis.

Authors:  Shu-Qiang Yuan; Yu-Tong Chen; Ze-Ping Huang
Journal:  J Gastrointest Surg       Date:  2017-07-27       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.